ERBB3 and cervical carcinoma: A comprehensive genomic and molecular biology study of cervical cancer in the 2017 Cancer Genome Atlas project1 first proposed ERBB3 as a new Significant Mutation Gene (SMG) in cervical cancer and ERBB3 (HER3) as a therapeutic target.